2seventy

NISIT RAWO 2seventy bio (NASDAQ:TSVT) traded higher premarket Thursday after announcing the completion of an asset purchase agreement under which Novo Nordisk (NVO) (OTCPK:NONOF) has acquired its Hemophilia A program and rights to certain other assets. The staff members working in the program will also join the pharma giant asContinue Reading